Tunbridge, VT, United States of America

Michael B Sporn

USPTO Granted Patents = 29 

 

Average Co-Inventor Count = 3.9

ph-index = 19

Forward Citations = 1,210(Granted Patents)


Location History:

  • Hanover, NH (US) (2011)
  • Turnbridge, VT (US) (2016 - 2017)
  • Tunbridge, VT (US) (2001 - 2019)

Company Filing History:


Years Active: 2001-2025

Loading Chart...
Loading Chart...
29 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Michael B. Sporn

Introduction: Michael B. Sporn, based in Tunbridge, Vermont, is an accomplished inventor with a notable array of 28 patents to his name. His work primarily focuses on developing novel pharmaceutical compositions, showcasing his expertise in medicinal chemistry and innovation in drug formulation.

Latest Patents: Among his latest noteworthy patents are the "Pyridyl analogs of 1-(2-cyano-3,12-dioxooleana-1,9(11)dien-28-oyl) imidazole" which outlines innovative pharmaceutical compositions. This invention represents a significant advancement in the field, providing new options for therapeutic applications and detailing the composition and potential uses of these pyridyl analogs.

Career Highlights: Throughout his career, Sporn has contributed significantly to the biomedical field. His experience with prestigious institutions such as Dartmouth College and Reata Pharmaceuticals, Inc. has allowed him to advance his research and enhance his contributions to the field of pharmaceuticals. His inventions have become critical in the development of new medications, demonstrating his commitment to improving healthcare through innovation.

Collaborations: Sporn has collaborated with distinguished colleagues including Gordon W. Gribble and Tadashi Honda. These professional relationships have not only enriched his research but have also led to a sharing of ideas that spur further innovations within their respective fields.

Conclusion: Michael B. Sporn is a passionate inventor whose work continues to impact the pharmaceutical industry profoundly. With his impressive patent portfolio and cooperative spirit, he remains a valuable asset to the world of medicinal research and innovation. His ongoing projects promise to lead to even more groundbreaking advancements in health solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…